Trial record 2 of 18 for:    SAILS

Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort (SAILS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Sponsor:
Information provided by (Responsible Party):
LUIS SEIJO MACEIRAS, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
ClinicalTrials.gov Identifier:
NCT02687997
First received: February 17, 2016
Last updated: September 2, 2016
Last verified: September 2016
  Purpose
Prospective study of sleep disordered breathing in a lung cancer screening cohort.

Condition Intervention
Sleep Apnea Hypopnea Syndrome
COPD
Emphysema
Lung Cancer
Other: poligraphy

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Prevalence of Sleep Apnea in a Lung Cancer Screening Cohort Meeting NLST Criteria

Resource links provided by NLM:


Further study details as provided by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz:

Primary Outcome Measures:
  • Prevalence of sleep apnea [ Time Frame: 1 year ]

Estimated Enrollment: 100
Study Start Date: February 2016
Estimated Study Completion Date: July 2017
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Diagnostic
Patients enrolled in lung cancer screening subjected to a sleep study.
Other: poligraphy
Sleep study
No Intervention: Contro
Patients enrolled in lung cancer screening not included in the diagnostic intervention arm

Detailed Description:
The proposed study is a prospective single arm study evaluating the prevalence of sleep disordered breathing in a cohort of lung cancer screening patients.
  Eligibility

Ages Eligible for Study:   55 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 55-75.
  • > 30 pack years tobacco exposure.
  • Enrolled in lung cancer screening program.

Exclusion Criteria:

  • Inability or unwillingness to undergo a home sleep study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02687997

Contacts
Contact: Luis M Seijo, MD, PhD 91 550 4800 ext 2418 luis.seijo@fjd.es
Contact: German Peces-Barba, MD, PhD 915504800 GPeces@fjd.es

Locations
Spain
Fundacion Jimenez Diaz Recruiting
Madrid, Spain, 28040
Contact: Luis M Seijo, MD, PhD    91 550 4800 ext 2418    luis.seijo@fjd.es   
Contact: German Peces-Barba, MD, PhD    91 550 4800    GPeces@fjd.es   
Sponsors and Collaborators
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
  More Information

Responsible Party: LUIS SEIJO MACEIRAS, Attending Physician, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
ClinicalTrials.gov Identifier: NCT02687997     History of Changes
Other Study ID Numbers: InsitutoFJD 
Study First Received: February 17, 2016
Last Updated: September 2, 2016

Additional relevant MeSH terms:
Lung Neoplasms
Sleep Apnea Syndromes
Emphysema
Sleep Apnea, Obstructive
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases
Apnea
Respiration Disorders
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on January 23, 2017